DE2463465C2 - - Google Patents

Info

Publication number
DE2463465C2
DE2463465C2 DE19742463465 DE2463465A DE2463465C2 DE 2463465 C2 DE2463465 C2 DE 2463465C2 DE 19742463465 DE19742463465 DE 19742463465 DE 2463465 A DE2463465 A DE 2463465A DE 2463465 C2 DE2463465 C2 DE 2463465C2
Authority
DE
Germany
Prior art keywords
hydroxycarbostyril
radical
general formula
acid
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE19742463465
Other languages
German (de)
English (en)
Inventor
Kazuyuki Tokushima Jp Nakagawa
Chiro Naruto Tokushima Jp Yoshizaki
Kaoru Tanimura
Shigeharu Tokushima Jp Tamada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP5831774A external-priority patent/JPS5310991B2/ja
Priority claimed from JP5831574A external-priority patent/JPS5310990B2/ja
Priority claimed from JP6782374A external-priority patent/JPS5310994B2/ja
Priority claimed from JP13071774A external-priority patent/JPS5156463A/ja
Priority claimed from JP13072774A external-priority patent/JPS5156473A/ja
Priority claimed from JP13071874A external-priority patent/JPS5156464A/ja
Priority claimed from JP14033974A external-priority patent/JPS5165770A/ja
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE2463465C2 publication Critical patent/DE2463465C2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • C07D215/32—Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19742463465 1974-05-22 1974-12-27 Expired - Lifetime DE2463465C2 (US20030199744A1-20031023-C00003.png)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP5831774A JPS5310991B2 (US20030199744A1-20031023-C00003.png) 1974-05-22 1974-05-22
JP5831574A JPS5310990B2 (US20030199744A1-20031023-C00003.png) 1974-05-22 1974-05-22
JP6782374A JPS5310994B2 (US20030199744A1-20031023-C00003.png) 1974-06-13 1974-06-13
JP13071774A JPS5156463A (ja) 1974-11-11 1974-11-11 Karubosuchirirujudotaino seizoho
JP13072774A JPS5156473A (ja) 1974-11-11 1974-11-11 Karubosuchirirujudotaino seizoho
JP13071874A JPS5156464A (ja) 1974-11-11 1974-11-11 Karubosuchirirujudotaino seizoho
JP14033974A JPS5165770A (ja) 1974-12-04 1974-12-04 Karubosuchirirujudotaino seizoho

Publications (1)

Publication Number Publication Date
DE2463465C2 true DE2463465C2 (US20030199744A1-20031023-C00003.png) 1990-04-12

Family

ID=27564952

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19742463465 Expired - Lifetime DE2463465C2 (US20030199744A1-20031023-C00003.png) 1974-05-22 1974-12-27

Country Status (3)

Country Link
DE (1) DE2463465C2 (US20030199744A1-20031023-C00003.png)
HK (1) HK19581A (US20030199744A1-20031023-C00003.png)
MY (1) MY8200090A (US20030199744A1-20031023-C00003.png)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NICHTS ERMITTELT *

Also Published As

Publication number Publication date
HK19581A (en) 1981-05-22
MY8200090A (en) 1982-12-31

Similar Documents

Publication Publication Date Title
AT363096B (de) Verfahren zur herstellung von neuen phthalazinderivaten und deren salzen
DE2513916C2 (de) N-(2-Piperidylmethyl)-2,5-bis (2,2,2-trifluoräthoxy)-benzamid
DE2024001B2 (de) Tetrahydrofurfuryloxyphenoxypropanolamine und deren pharmakologisch verträgliche Säureadditionssalze und Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
DE2461860C2 (US20030199744A1-20031023-C00003.png)
DE2461604C2 (US20030199744A1-20031023-C00003.png)
DE1593579B1 (de) Hydroxy-cyclohexylamine,deren physiologisch vertraeglichen Saeureadditionssalze und Verfahren zu ihrer Herstellung
DE2044172C3 (de) Pyrrolderivate, ein Verfahren zu ihrer Herstellung und Arzneimittel
DE1518452C3 (de) 4 substituierte 2 Benzhydryl 2 butanol Derivate und Verfahren zu ihrer Herstellung
DE2724478C2 (de) 5,11-Dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-on-derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
CH385196A (de) Verfahren zur Herstellung analeptisch wirksamer N-substituierter Aminonorcamphanderivate
DE2117358C3 (de) 4'-Aminomethyl-spiro eckige Klammer auf dibenzo eckige Klammer auf a,d eckige Klammer zu cycloheptadi-(oder tri-) en-5,2'-(1 \3'-dioxolan) eckige Klammer zu -Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltene Arzneimittel
DE2463465C2 (US20030199744A1-20031023-C00003.png)
DE2522218C3 (de) Zusammensetzung für die Human- oder Veterinärmedizin, Methylaminderivate und Verfahren zu deren Herstellung
DE1802297C3 (de) Isopropylaminderivate und Verfahren zu ihrer Herstellung
DE2463468C2 (US20030199744A1-20031023-C00003.png)
DE2628464A1 (de) Xanthensaeure-derivate und ihr herstellungsverfahren
AT244932B (de) Verfahren zur Herstellung von neuen Phenyläthanolaminen und ihren Salzen
DE1901175A1 (de) Verfahren zur Herstellung von neuen Piperidinderivaten
DE2235667A1 (de) Hexahydrobenz/e/indolderivate
AT331215B (de) Verfahren zur herstellung von neuen aminobenzylaminen sowie deren saureadditionssalzen
EP0003298A2 (de) 4-Hydroxy-2-benzimidazolin-thion-Derivate, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
DE1593579C (US20030199744A1-20031023-C00003.png)
DE1795259C3 (de) N (2 Benzoylamino 6 chlor benzyl) N methyl glycin morphohd Ausscheidung aus 1518375
DE1470155A1 (de) Neue Pyrrolidinverbindungen,ihre Saeureadditionssalze,sowie Verfahren zu deren Herstellung
CH526535A (de) Verfahren zur Herstellung neuer Pyrrolidin-1-carboxamidinderivate

Legal Events

Date Code Title Description
Q172 Divided out of (supplement):

Ref country code: DE

Ref document number: 2461596

8110 Request for examination paragraph 44
AC Divided out of

Ref country code: DE

Ref document number: 2461596

Format of ref document f/p: P

AC Divided out of

Ref country code: DE

Ref document number: 2461596

Format of ref document f/p: P

D2 Grant after examination
8364 No opposition during term of opposition